The epidermal growth factor (EGF) family of tyrosine kinase receptors (ErbB1, -2, -3, and -4) and their ligands are involved in cell differentiation, proliferation, migration, and carcinogenesis. However, it has proven difficult to link a given ErbB receptor to a specific biological process since most cells express multiple ErbB members that heterodimerize, leading to receptor cross-activation. In this study, we utilize carcinoma cells depleted of ErbB2, but not other ErbB receptor members, to specifically examine the role of ErbB2 in carcinoma cell migration and invasion. Cells stimulated with EGF-related peptides show increased invasion of the extracellular matrix, whereas cells devoid of functional ErbB2 receptors do not. ErbB2 facilitates cell invasion through extracellular regulated kinase (ERK) activation and coupling of the adaptor proteins, p130CAS and c-CrkII, which regulate the actin-myosin cytoskeleton of migratory cells. Overexpression of ErbB2 in cells devoid of other ErbB receptor members is sufficient to promote ERK activation and CAS/Crk coupling, leading to cell migration. Thus, ErbB2 serves as a critical component that couples ErbB receptor tyrosine kinases to the migration/invasion machinery of carcinoma cells.
Skip Nav Destination
Article navigation
24 January 2000
Article|
January 24 2000
ErbB2 Is Necessary for Induction of Carcinoma Cell Invasion by Erbb Family Receptor Tyrosine Kinases
Kathryn S.R. Spencer,
Kathryn S.R. Spencer
aDepartment of Immunology, The Scripps Research Institute, La Jolla, California 92037
Search for other works by this author on:
Diana Graus-Porta,
Diana Graus-Porta
bFriedrich Miescher Institute, CH-4002 Basel, Switzerland
Search for other works by this author on:
Jie Leng,
Jie Leng
aDepartment of Immunology, The Scripps Research Institute, La Jolla, California 92037
Search for other works by this author on:
Nancy E. Hynes,
Nancy E. Hynes
bFriedrich Miescher Institute, CH-4002 Basel, Switzerland
Search for other works by this author on:
Richard L. Klemke
Richard L. Klemke
aDepartment of Immunology, The Scripps Research Institute, La Jolla, California 92037
Search for other works by this author on:
Kathryn S.R. Spencer
aDepartment of Immunology, The Scripps Research Institute, La Jolla, California 92037
Diana Graus-Porta
bFriedrich Miescher Institute, CH-4002 Basel, Switzerland
Jie Leng
aDepartment of Immunology, The Scripps Research Institute, La Jolla, California 92037
Nancy E. Hynes
bFriedrich Miescher Institute, CH-4002 Basel, Switzerland
Richard L. Klemke
aDepartment of Immunology, The Scripps Research Institute, La Jolla, California 92037
Abbreviations used in this paper: β-gal, β-galactosidase; BTC, β-cellulin; CAS, crk-associated substrate; ECM, extracellular matrix; ERK, extracellular regulated kinase; FBM, fibroblast basal media; MAP, mitogen-activated protein; MBP, myelin basic protein; MEK, MAP kinase kinase; NDF, neu differentiation factor; p130CAS, Crk-associated substrate; SH2, src-homology 2 domain.
Received:
August 12 1999
Revision Requested:
November 04 1999
Accepted:
December 10 1999
Online ISSN: 1540-8140
Print ISSN: 0021-9525
© 2000 The Rockefeller University Press
2000
The Rockefeller University Press
J Cell Biol (2000) 148 (2): 385–397.
Article history
Received:
August 12 1999
Revision Requested:
November 04 1999
Accepted:
December 10 1999
Citation
Kathryn S.R. Spencer, Diana Graus-Porta, Jie Leng, Nancy E. Hynes, Richard L. Klemke; ErbB2 Is Necessary for Induction of Carcinoma Cell Invasion by Erbb Family Receptor Tyrosine Kinases. J Cell Biol 24 January 2000; 148 (2): 385–397. doi: https://doi.org/10.1083/jcb.148.2.385
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement